{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:07:32Z","timestamp":1793210852747,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.radonc.2021.11.023","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T10:21:30Z","timestamp":1638613290000},"page":"317-322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["LITE SABR M1: A phase I trial of Lattice stereotactic body radiotherapy for large tumors"],"prefix":"10.1016","volume":"167","author":[{"given":"Sai","family":"Duriseti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A.","family":"Kavanaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Basarabescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aadel","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Henke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Samson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew B.","family":"Spraker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2021.11.023_b0005","article-title":"Palliative radiotherapy","volume":"360","author":"Spencer","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.radonc.2021.11.023_b0010","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jtho.2018.06.007","article-title":"Histology, tumor volume, and radiation dose predict outcomes in NSCLC patients after stereotactic ablative radiotherapy","volume":"13","author":"Shiue","year":"2018","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0015","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1001\/jamaoncol.2019.0192","article-title":"Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases: a randomized phase 2 trial","volume":"5","author":"Nguyen","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0020","doi-asserted-by":"crossref","DOI":"10.1186\/s13014-017-0773-4","article-title":"Lung metastases treated with stereotactic body radiotherapy: the RSSearch\u00ae patient Registry\u2019s experience","volume":"12","author":"Ricco","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0025","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.ijrobp.2013.08.020","article-title":"The impact of tumor size on outcomes after stereotactic body radiation therapy for medically inoperable early-stage non-small cell lung cancer","volume":"87","author":"Allibhai","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0030","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.cllc.2016.11.020","article-title":"Stereotactic body radiotherapy for large (> 5 cm) non\u2013small-cell lung cancer","volume":"18","author":"Peterson","year":"2017","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.radonc.2021.11.023_b0035","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ijrobp.2015.01.045","article-title":"Stereotactic body radiation therapy for non-small cell lung cancer tumors greater than 5 cm: safety and efficacy","volume":"92","author":"Woody","year":"2015","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0040","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/cncr.30375","article-title":"Multi-institutional experience of stereotactic body radiotherapy for large (\u22655 centimeters) non\u2013small cell lung tumors","volume":"123","author":"Verma","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.11.023_b0045","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.prro.2017.04.014","article-title":"Stereotactic body radiation therapy for early-stage non-small cell lung cancer: executive summary of an ASTRO evidence-based guideline","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijrobp.2019.01.073","article-title":"A current review of spatial fractionation: back to the future?","volume":"104","author":"Billena","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.11.023_b0055","doi-asserted-by":"crossref","DOI":"10.1667\/RADE-20-00066.1","article-title":"The technical and clinical implementation of LATTICE radiation therapy (LRT)","volume":"194","author":"Wu","year":"2020","journal-title":"Radiat Res"},{"key":"10.1016\/j.radonc.2021.11.023_b0060","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1177\/153303460600500608","article-title":"Spatially fractionated GRID radiation treatment of advanced neck disease associated with head and neck cancer","volume":"5","author":"Huhn","year":"2006","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2021.11.023_b0065","doi-asserted-by":"crossref","first-page":"S526","DOI":"10.1016\/j.ijrobp.2009.07.1200","article-title":"Spatially Fractionated Grid Radiation (SFGRT): a novel approach in the management of recurrent and unresectable soft tissue sarcoma","volume":"75","author":"Mohiuddin","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.11.023_b0070","doi-asserted-by":"crossref","unstructured":"Blanco Suarez JM, Amendola BE, Perez N, Amendola M, Wu X. The use of Lattice Radiation Therapy (LRT) in the treatment of bulky tumors: a case report of a large metastatic mixed Mullerian Ovarian Tumor. Cureus. 7(11). doi:10.7759\/cureus.389.","DOI":"10.7759\/cureus.389"},{"key":"10.1016\/j.radonc.2021.11.023_b0075","doi-asserted-by":"crossref","unstructured":"Amendola BE, Perez NC, Wu X, Amendola MA, Qureshi IZ. Safety and efficacy of lattice radiotherapy in voluminous non-small cell lung cancer. Cureus. 11(3). doi:10.7759\/cureus.4263","DOI":"10.7759\/cureus.4263"},{"key":"10.1016\/j.radonc.2021.11.023_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.adro.2020.100639","article-title":"Spatially fractionated stereotactic body radiotherapy (Lattice SBRT) for large tumors","author":"Duriseti","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0085","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM Task Group 101: stereotactic body radiation therapy: the report of TG101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2021.11.023_b0090","unstructured":"PROMIS. Accessed December 26, 2020. https:\/\/www.healthmeasures.net\/explore-measurement-systems\/promis."},{"key":"10.1016\/j.radonc.2021.11.023_b0095","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2019.3332","article-title":"Assessment of adverse events from the patient perspective in a phase 3 metastatic castration-resistant prostate cancer clinical trial","volume":"6","author":"Dueck","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/1740774520975120","article-title":"Composite grading algorithm for the National Cancer Institute\u2019s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)","volume":"18","author":"Basch","year":"2021","journal-title":"Clin Trials"},{"key":"10.1016\/j.radonc.2021.11.023_b0105","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1200\/JCO.2016.71.4410","article-title":"United States population-based estimates of patient-reported outcomes measurement information system symptom and functional status reference values for individuals with cancer","volume":"35","author":"Jensen","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.11.023_b0110","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.annonc.2020.09.016","article-title":"Safety of thoracic radiotherapy in patients with prior immune-related adverse events from immune checkpoint inhibitors","volume":"31","author":"Shaverdian","year":"2020","journal-title":"Ann Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021090186?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021090186?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:23:08Z","timestamp":1759123388000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021090186"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":22,"alternative-id":["S0167814021090186"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.11.023","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.06.05.21257825","asserted-by":"object"}]},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LITE SABR M1: A phase I trial of Lattice stereotactic body radiotherapy for large tumors","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}